Submitted by Anonymous (not verified) on 25 March 2026 - 9:04
Human medicines European public assessment report (EPAR): Tepezza, teprotumumab, Date of authorisation: 19/06/2025, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tepezza, teprotumumab, Date of authorisation: 19/06/2025, Revision: 1, Status: Authorised